Carglumic acid clinical trials
Also written Carbaglu.
How each study uses carglumic acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 18 Mar 2010 · CARBAGLU · NDA 022562 (FDA, Drugs@FDA)
- European Union
- 24 Jan 2003 · Carbaglu · EMEA/H/C/000461 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2012 (2)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 6
Mendel Tuchman (3) · National Taiwan University Hospital (1) · King Abdullah International Medical Research Center (1) · Children's Hospital of Philadelphia (1)
Studies
Open first, then newest update. How each study uses carglumic acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Long-term Efficacy of Carglumic Acid in Organic Acidemia.CompletedNot applicableNational Taiwan University HospitalNCT04284917Written as Carglumic Acid (Carbaglu®)
- Short-Term Outcome of N-Carbamylglutamate in the Treatment of Acute HyperammonemiaCompletedPhase 2Mendel TuchmanNCT01599286Written as Carbaglu
- N-Carbamylglutamate (Carbaglu) In The Treatment Of HyperammonemiaStatus unknownPhase 2/3Mendel TuchmanNCT00843921Written as N-carbamylglutamate
- Carglumic Acid in Methylmalonic Acidemia and Propionic AcidemiaCompletedPhase 3King Abdullah International Medical Research CenterNCT02426775Written as Carglumic Acid
- Long-term Outcome of N-Carbamylglutamate Treatment in Propionic Acidemia and Methylmalonic AcidemiaTerminatedPhase 2Mendel TuchmanNCT01597440Written as N-carbamylglutamate
- Increasing Ureagenesis in Inborn Errors of Metabolism With N-CarbamylglutamateWithdrawnPhase 2Children's Hospital of PhiladelphiaNCT01341379Written as N-carbamylglutamate
Codes
What other systems call carglumic acid · ClinicalTrials.gg INT005263
- MeSH (NLM) C528449carglumic acidOne source NLM
- UNII (FDA) 5L0HB4V1EWCARGLUMIC ACIDConfirmed FDA, NLM, Wikidata
- RxNorm 401713Confirmed FDA, Wikidata
- Wikidata Q822884carglumic acidConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C76884Carglumic AcidOne source FDA
- DrugBank DB06775One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C528449 | carglumic acid | One source NLM |
| UNII (FDA) | 5L0HB4V1EW | CARGLUMIC ACID | Confirmed FDA, NLM, Wikidata |
| RxNorm | 401713 | — | Confirmed FDA, Wikidata |
| Wikidata | Q822884 | carglumic acid | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C76884 | Carglumic Acid | One source FDA |
| DrugBank | DB06775 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.